Salvage re-irradiation for recurrent head and neck cancer.
about
A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers.Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience.A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experienceSecond-line treatment of recurrent HNSCC: tumor debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol.Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo ClinicNew developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapyDosimetric analysis of isocentrically shielded volumetric modulated arc therapy for locally recurrent nasopharyngeal cancer.Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer.Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.Clinical application of intensity-modulated radiotherapy for head and neck cancer.The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets.Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors.A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy.Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma.Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy.Management of recurrent head and neck cancer: recent progress and future directions.Emerging applications of stereotactic body radiation therapy for head and neck cancer.Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck.IMRT and IGRT in head and neck cancer: Have we delivered what we promised?Reirradiation for recurrent head and neck cancer.Decision making in the management of recurrent head and neck cancer.Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles.Functional and quality-of-life outcomes after reirradiation for head and neck cancer.Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.Brachytherapy for radiotherapy-resistant head and neck cancer: A review of a single center experience.Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence.Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer.Reirradiation of head and neck cancer: Long-term disease control and toxicity.High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck.Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes.Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes.SBRT Treatment of Multiple Recurrent Auricular Squamous Cell Carcinomas Following Surgical and Conventional Radiation Treatment Failure.Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol.
P2860
Q33592363-9E59B161-4B8B-4694-98B9-E25075414B3DQ34408305-77A4A7FB-B042-42A2-80A8-D17680CB3944Q36018430-6EDB4EC7-232E-4792-B01B-051985529B19Q36480951-6C70CF98-4BDD-4C07-8A2A-B73AA720AEC4Q36593737-F58CA1D0-3762-4303-9E66-0B3D284D151DQ36783381-0471D2DD-24B5-4D8C-8AB5-A0AF3910AC9DQ36807138-7246DA5C-5660-4733-82C0-24EC6280C675Q36828148-75AF4FD6-F78E-4B54-AB31-199EAABB9C75Q36897935-8C173B4C-FE26-4047-8664-DF90F2CB687FQ37025532-F47A1AFC-4CB0-42EA-9CD8-842340CA0827Q37203612-DE4FF3C0-6D1D-48DA-9588-481795373B1BQ37217016-C557ACAD-60AD-4AAF-810B-56FBD0BB7167Q37365870-B0A2289B-D868-42A3-B99A-BA7A94C8356CQ37392508-B45C49F1-5D0B-4641-BE44-603AB67122BAQ37445514-33F1ECEE-F33F-4FBF-8AAE-BA3FADF49B70Q37549496-09482838-8587-4BBD-AFD7-ED8418384E67Q37609476-47C6F5A6-DAE3-460A-8722-48FE213B6386Q37919985-88AA9FA1-F9E2-4108-8F1A-6B45A32D9116Q37921278-6E3B7599-B905-463B-9493-B5FDC1E1ED65Q37934972-5B08A4C5-B51E-4887-A2A5-948D01910F1BQ37952659-E7F6F741-823D-4D94-BA0F-B2C99BFE1FD6Q38038841-6018661F-29BF-4BAF-A275-EEE2D8CE215EQ38055496-1B97B64C-C31A-44B8-8929-47BC315AF464Q38087569-4B8750E1-6B7B-433E-9D6A-F5A890923B61Q38099657-95C989E6-8241-4AE4-B5AD-5B8739485217Q38171349-F8974DE6-7438-4224-A023-E180C707E6C0Q38183707-6C919A2A-1814-4DBE-B69A-8FC337D950F4Q38755868-F0662EF7-32BB-422C-893A-97B29607319FQ38844023-CBBFE021-F016-4180-B116-BDD4D4A677FFQ39044493-543D24F9-CC3D-4025-805F-DB28EF6227AAQ39322631-5CCD8BC9-9280-46C6-A872-2E154B4A8C67Q40542708-22934CC1-FB8E-4D28-83AD-DA4E1F6BE1F0Q41039788-3013FB49-C175-41D2-9060-9D2AED005618Q41039828-ABDCFFEF-D449-41D2-BC30-8881723B8CBDQ41107300-8849121C-72D6-4B7D-8BC5-4C73BA9D3637Q41547717-C67409D0-C963-4205-B623-83F89EA70685Q41644078-A2C30908-BD11-41D2-953C-D6679E24D289Q41887034-971AD184-EAED-49F2-AE90-D59B4262A28AQ42013872-1E32083D-1D83-4A1A-9596-7D95BCFE7BFAQ43076662-562083B3-2EB8-4742-AAD8-71B2675DFE45
P2860
Salvage re-irradiation for recurrent head and neck cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Salvage re-irradiation for recurrent head and neck cancer.
@ast
Salvage re-irradiation for recurrent head and neck cancer.
@en
type
label
Salvage re-irradiation for recurrent head and neck cancer.
@ast
Salvage re-irradiation for recurrent head and neck cancer.
@en
prefLabel
Salvage re-irradiation for recurrent head and neck cancer.
@ast
Salvage re-irradiation for recurrent head and neck cancer.
@en
P2093
P1476
Salvage re-irradiation for recurrent head and neck cancer.
@en
P2093
Ashwatha Narayana
David Pfister
Dennis Kraus
Ennapadam S Venkatraman
James Mechalakos
Jatin Shah
Joanne Zhung
Justin E Bekelman
Kelvin Chan
Michael J Zelefsky
P304
P356
10.1016/J.IJROBP.2006.12.055
P407
P577
2007-03-26T00:00:00Z